跳至主要内容
临床试验/TCTR20230504003
TCTR20230504003尚未招募3 期

Efficacy of Vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with Proton Pump Inhibitor-Refractory Functional Dyspepsia: A Pilot Study

Rajavithi Hospital0 个研究点目标入组 60 人开始时间: 2023年5月4日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age greater than 18 years old,
  • 2.Diagnosed functional dyspepsia by ROME IV criteria with persistent symptoms after four-week duration of standard dose Proton Pump Inhibitor,
  • 3.No significant Gastroduodenal lesions such as no gastric ulcer, no duodenal ulcer and no gastroduodenal neoplasm by Esophagogastroduodenoscopy
  • 4.Negative for H.pylori test for at least 3 months

排除标准

  • 1. Severe or uncontrolled co-morbidities such as chronic liver disease, end stage renal disease, chronic lungs disease, heart disease and cancer
  • 2. On pregnancy or on lactation

研究者

相似试验